RECENT POSTS
- Your First Move For Wednesday November 10th
- Web Extra: The Best Trades In Tech
- Pops & Drops: UPS, Electronic Arts...
- Take Your Position: Retail Earnings
- The Return of Dividend Investing?
- Should You Believe in this Rally?
- Trading in this Technicals-Driven Market
- HALFTIME REPORT: How to Trade Senator Dodd's Financial Reforms
FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our "Question of the Day" right now.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a recap email every Friday after the show!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Text Size 
 |
All this week, Fast Money is highlighting some little-known stocks that are making big impressions in the private equity world of hedge funds.
As a scientific equipment maker, Thermo Fisher Scientific [TMO
Loading...
()
] might seem like a nice, safe defensive healthcare play for a swooning economy. But, according to Goldman Sachs, many hedge funds see more to it than that, which is why they’re piling into the stock.
To start, the company just got FDA approval for a test that detects the deadly staph superbug – an illness that is reaching epidemic proportions in parts of the U.S.
And it doesn’t end there. Thermo Fisher and the broader lab equipment sector are tapped into a sea chance of sorts as 78 million baby boomers anticipate more doctor visits as they grow older.
That’s why the fastest money on the Street has put TMO under the microscope – and they like what they see.
So does Pete Najarian. This is a great stock because it’s consistent and predictable but still manages to deliver growth, he said, which is precisely why the hedge funds are buying it.
Jeff Macke stopped short of giving TMO a buy or sell recommendation, saying this is one that requires some homework due to the volatile nature of its related industries.
______________________________________________________
Got something to to say? Send us an e-mail at and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send those e-mails to .
Trader disclosure: On Apr. 17, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders: Najarian Owns (AAPL), (BIIB), (CSCO), (ETFC), (NOK), (TSO), (XLF), (YHOO), (BSC) Calls, (CHK) Calls, (COP) Calls, (GOOG) Calls, (MSFT) Calls, (POT) Calls; Finerman’s Firm Is Short Pounds, (IYR), (IJR), (SPY), (IWM), (MDY), (COF), Owns (BJS), (MO), (MSFT), (NYX), (SUN), (TSO), (VLO), (YHOO); Finerman Owns (GS); Finerman’s Firm and Finerman Own (FLS); Macke Owns (MSFT), (DIS), (YHOO), (INTC)
Charles Schwab Is A Sponsor Of "Fast Money"
GE Is The Parent Company Of CNBC
NBC Universal Is The Parent Company Of CNBC
Data is a real-time snapshot *Data is delayed at least 15 minutes